prosperousguy$AFFY Excellent Rev H&S here. A break of $21.25 looks like a 3 to 4 point run higher. Maybe even a gap higher. http://fsc.bz/3Qa #WORDEN
Mar. 20 at 1:23 PM
QuicktradersBiotech $AFFY consolidating, good entry point. They have Hematide, Anemia drug that will compete with Amgen.
Mar. 15 at 10:17 AM
EVCGroup@AdamFeuerstein on 10 biotech's w/ trial results coming $DCTH, $AFFY, $NVLT, $VRTX, $OPTR, $MDVN, $GENZ, $AMGN, $ALTH http://bit.ly/9Jw9Zn
Feb. 4 at 8:55 AM
adamfeuerstein$AFFY CEO: ESA biosimilars will face tough FDA safety scrutiny. Response to competition question against hematide. #jpm10
Jan. 13 at 12:44 PM